Use of healthcare services and prescription medication prior to sarcoma diagnosis in children, adolescents, and young adults in 1997–2020: a population-based cohort study
Reducing the diagnostic interval in early-life sarcomas should be explored as a low-cost complement to new, advanced treatments to improve survival. Efforts should focus on improving the selection of CAYA with musculoskeletal symptoms for early referral and a better understanding of the diagnostic pathway within the secondary healthcare system.
Authors
- Olafur B. Davidsson (ORCID: https://orcid.org/0000-0002-7226-5409)
- Henrik Hjalgrim (ORCID: https://orcid.org/0000-0002-4436-6798)
- Signe Holst Søegaard (ORCID: https://orcid.org/0000-0003-4857-7186)
- Ninna Aggerholm‐Pedersen (ORCID: https://orcid.org/0000-0002-6859-5296)
- Daniel Dybdal (ORCID: https://orcid.org/0000-0001-5039-0367)
- Michael Mørk Petersen (ORCID: https://orcid.org/0000-0002-2324-6420)
- Lisa Lyngsie Hjalgrim (ORCID: https://orcid.org/0000-0001-5186-3365)
- Klaus Rostgaard (ORCID: https://orcid.org/0000-0001-6220-9414)
Institutions
- Statens Serum Institut (DK)
- University of Copenhagen (DK)
- Aarhus University Hospital (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
- Danish Cancer Society (DK)
Publication Details
- Journal
- Cancer Causes & Control
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1007/s10552-025-02077-1
- Primary Topic
- Testicular diseases and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00